tm logo
USION PHARMACEUTICALS INC.
Live/Registered
REGISTERED

on 25 Jul 2023

Last Applicant/ Owned by

270 Longwood Road South

Hamilton, Ontario

CA

L8P0A6

Serial Number

90667636 filed on 23rd Apr 2021

Registration Number

7122418 registered on 25th Jul 2023

in the Principal Register

Correspondent Address

Jonathan M. Gelchinsky

Jonathan M. Gelchinsky

254 COMMERCIAL STREET

PORTLAN, ME 04101

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

USION PHARMACEUTICALS INC.

Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells, including but not limited to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use

Classification Information


Class [005]
Pharmaceutical Products


Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells, including but not limited to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use


First Use Date in General

27th Mar 2023

First Use Date in Commerce

27th Mar 2023

Mark Details


Serial Number

No 90667636

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 37653/3000L

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.09.05 -

Atoms or molecular models

Legal History


Show more

Status DateAction Taken
25th Jul 2023REGISTERE-PRINCIPAL REGISTER
25th Jul 2023NOTICE O REGISTRATION CONIRMATION EMAILE
23rd Jun 2023NOTICE O ACCEPTANCE O STATEMENT O USE E-MAILE
22nd Jun 2023ALLOWE PRINCIPAL REGISTER - SOU ACCEPTE
06th Jun 2023CASE ASSIGNE TO INTENT TO USE PARALEGAL
06th Jun 2023STATEMENT O USE PROCESSING COMPLETE
15th May 2023TEAS STATEMENT O USE RECEIVE
15th May 2023USE AMENMENT ILE
04th May 2023NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE
02th May 2023SOU TEAS EXTENSION RECEIVE